Dr. Felicia Balzano, MD

Dr. Balzano practices at Gundersen Lutheran Medical Center - Dialysis in La Crosse, Wisconsin.

Dr. Balzano's NPI, 1467830711, was assigned on May 7, 2015. Dr. Balzano graduated from New York Medical College in 2015. Dr. Balzano's California license number on file is A168902.

Dr. Balzano's primary practice is Gundersen Lutheran Medical Center - Dialysis, at 1910 South Ave, Heritage Building 2 West, La Crosse, WI 54601 in La Crosse County. The practice phone is (608) 775-3176.

Dr. Balzano's primary practice is Gundersen Lutheran Medical Center - Dialysis in La Crosse, Wisconsin. Dr. Balzano is also affiliated with Gundersen Lutheran Medical Center. The medical group on file is Gundersen Lutheran Medical Center. Dmand AI also links Dr. Balzano to 1 more hospital and 1 medical group, each named with a free account. Dr. Balzano's employer is on file too: a dialysis center.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Balzano practices, 3 sites in all. Vendor and product names are available with a free account.

Urology is Dr. Balzano's primary specialty in the NPI Registry, under taxonomy code 208800000X. Dr. Balzano is board certified in urology by the American Board of Urology. Dmand AI has Dr. Balzano's licenses on file in 5 states: California, Colorado, Maryland, Minnesota and Wisconsin.

Dmand AI lists bladder disease, enlarged prostate transurethral surgery (TURP), kidney removal surgery, urinary endoscopy and UTI among the conditions Dr. Balzano treats.

CMS data shows 198 Medicare services from Dr. Balzano across 8 procedure codes in 2024, for 184 Medicare patients. Medicare paid $16,556 for them.

CMS counts 184 Medicare patients who saw Dr. Balzano in 2024. The largest group is 65 to 74, with 73 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 14% are also on Medicaid. Their average risk score is 1.65, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Balzano's median patient age at 69, with 36% women.

In 2024, Dr. Balzano wrote 102 Medicare Part D claims for 59 patients. 99% of them were for generic drugs. CMS names the drug for 52 of them, across 2 drugs with 11 or more claims each, at $573 in total drug cost. In 2022, CMS named 111 claims across 5 drugs.

Dr. Balzano accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 9 papers to Dr. Balzano, published from 2019 to 2025. 2022 was the busiest year, with 2. The most frequent topics are Urethral Stricture, Constriction, Pathologic and Cystoscopy. Dr. Balzano has published most often in Transl Androl Urol. Dr. Balzano's most frequent co-authors are Jonathan N. Warner, MD, Heather M. Barbier, MD and Kevin G. Chan, MD.

CMS Open Payments shows 52 general payments to Dr. Balzano from 13 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 58% of the total. Boston Scientific Corporation paid the most, $2,800.

Dr. Balzano graduated from New York Medical College in 2015.

Dr. Balzano is in network with 14 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. Medicare plans come from the most carriers, 8. Check the plan with the practice before a visit.